Kraematon Investment Advisors »

Intellia Therapeutics shares owned by Kraematon Investment Advisors

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Kraematon Investment Advisors from 13F filings

Historical chart of Kraematon Investment Advisors investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Kraematon Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Kraematon Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $270k 9.8k 27.51
2023-12-31 $326k 11k 30.49
2023-09-30 $365k 12k 31.62
2023-06-30 $511k 13k 40.78
2023-03-31 $312k 8.4k 37.27
2022-12-31 $196k 5.6k 34.89
2022-09-30 $324k 5.8k 55.96
2022-06-30 $318k 6.1k 51.79
2022-03-31 $446k 6.1k 72.64
2021-12-31 $724k 6.1k 118.20